Make great efforts to improve the levels of refined diagnosis and individualized treatment for microvascular invasion of liver cancer in China
10.3760/cma.j.issn.1007-8118.2019.10.001
- VernacularTitle: 努力提高我国肝癌微血管侵犯的精细化诊断和个体化治疗水平
- Author:
Wenming CONG
1
;
Mengchao WU
2
Author Information
1. Department of Pathology, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, China
2. Department of Surgery, Eastern Hepatobiliary Surgery Hospital, Navy Military Medical University, Shanghai 200438, China
- Publication Type:Journal Article
- Keywords:
Liver neoplasms;
Microvascular invasion;
Diagnosis;
Pathology;
Clinic
- From:
Chinese Journal of Hepatobiliary Surgery
2019;25(10):721-724
- CountryChina
- Language:Chinese
-
Abstract:
Recurrence after surgical resection is a bottleneck that severely restricts the long-term efficacy of patients with liver cancer, mainly referring to hepatocellular carcinoma and intrahepatic cholangiocarcinoma. As the most representative pathobiological feature of liver cancer, microvascular invasion (MVI) should be taken as an important focus to break through the bottleneck of postoperative recurrence. The new pathological diagnostic criteria and classification scheme of MVI has been written into the current " Guidelines for Diagnosis and Treatment of Primary Liver Cancer" of China. It is not only an important pathological indication for the clinical implementation of anti-recurrence therapy after operation, but also an key pathological basis for the clinical formulation of postoperative anti-recurrent therapy. Therefore, we intend to investigate how to make better use of it. From now on, multidisciplinary research should be strengthened in order to make real progress in the occurrence mechanism, migration pathway, distribution pattern, accurate identification and effective treatment of MVI in order to further improve the long-term efficacy of patients with liver cancer.
